Philip Beer

8.7k total citations · 2 hit papers
87 papers, 4.6k citations indexed

About

Philip Beer is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Philip Beer has authored 87 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 40 papers in Hematology and 33 papers in Genetics. Recurrent topics in Philip Beer's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (24 papers), Acute Myeloid Leukemia Research (18 papers) and Chronic Myeloid Leukemia Treatments (18 papers). Philip Beer is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (24 papers), Acute Myeloid Leukemia Research (18 papers) and Chronic Myeloid Leukemia Treatments (18 papers). Philip Beer collaborates with scholars based in United Kingdom, Canada and United States. Philip Beer's co-authors include Anthony R. Green, Claire Harrison, Wendy N. Erber, Mary Frances McMullin, Linda M. Scott, Peter J. Campbell, Connie J. Eaves, Mike Scott, Michael R. Stratton and D. Gary Gilliland and has published in prestigious journals such as Nature, New England Journal of Medicine and Nature Communications.

In The Last Decade

Philip Beer

85 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

JAK2 Exon 12 Mutations in Polycythemia Vera and Idiopathic Erythrocytosis

2007 898 citations Mike Scott, Philip Beer et al. profile →
Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report

2020 260 citations Stuart Lacy, Sharon Barrans et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip Beer United Kingdom	32	2.7k	2.4k	2.3k	955	722	87	4.6k
Andrew Chase United Kingdom	39	2.5k 0.9×	2.7k 1.1×	3.5k 1.5×	1.5k 1.6×	619 0.9×	103	5.9k
Thomas Mercher France	27	1.9k 0.7×	2.4k 1.0×	2.0k 0.9×	683 0.7×	469 0.6×	53	4.0k
Ronald Paquette United States	33	2.4k 0.9×	1.5k 0.6×	3.2k 1.4×	1.1k 1.2×	610 0.8×	119	5.0k
Hana Raslová France	29	3.2k 1.2×	2.4k 1.0×	3.1k 1.4×	1.1k 1.1×	785 1.1×	75	5.2k
Taghi Manshouri United States	43	3.2k 1.2×	3.0k 1.3×	3.1k 1.4×	1.2k 1.3×	1.3k 1.8×	143	6.2k
E. Joanna Baxter United Kingdom	20	4.1k 1.5×	2.4k 1.0×	3.3k 1.5×	2.2k 2.3×	726 1.0×	41	5.6k
François Delhommeau France	26	3.7k 1.4×	2.7k 1.1×	3.0k 1.3×	1.4k 1.5×	657 0.9×	81	5.2k
Rebecca F. McClure United States	31	2.9k 1.1×	2.0k 0.8×	2.4k 1.0×	1.4k 1.5×	515 0.7×	64	4.5k
George S. Vassiliou United Kingdom	36	4.4k 1.6×	5.1k 2.1×	4.2k 1.9×	1.6k 1.7×	1.1k 1.5×	108	8.4k
Thoas Fioretos Sweden	39	1.1k 0.4×	2.5k 1.1×	2.5k 1.1×	558 0.6×	981 1.4×	153	5.6k

Countries citing papers authored by Philip Beer

Since Specialization

Citations

This map shows the geographic impact of Philip Beer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Beer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Beer more than expected).

Fields of papers citing papers by Philip Beer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Beer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Beer. The network helps show where Philip Beer may publish in the future.

Co-authorship network of co-authors of Philip Beer

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Beer. A scholar is included among the top collaborators of Philip Beer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Beer. Philip Beer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bellanger, Céline, Benoît Tessoulin, Christelle Dousset, et al.. (2024). Selective pharmacologic targeting of CTPS1 shows single-agent activity and synergizes with BCL2 inhibition in aggressive mantle cell lymphoma. Haematologica. 109(8). 2574–2584. 1 indexed citations

Crouch, Simon, Daniel Painter, Sharon Barrans, et al.. (2022). Molecular subclusters of follicular lymphoma: a report from the United Kingdom’s Haematological Malignancy Research Network. Blood Advances. 6(21). 5716–5731. 17 indexed citations

Tsimberidou, Apostolia M., Philip Beer, Carrie Cartwright, et al.. (2021). Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid Tumors. Clinical Cancer Research. 27(13). 3584–3594. 46 indexed citations

Pellacani, Davide, Naoto Nakamichi, Colin A. Hammond, et al.. (2020). MYC-induced human acute myeloid leukemia requires a continuing IL-3/GM-CSF costimulus. Blood. 136(24). 2764–2773. 18 indexed citations

Lacy, Stuart, Sharon Barrans, Philip Beer, et al.. (2020). Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report. Blood. 135(20). 1759–1771. 260 indexed citations breakdown →

Caeser, Rebecca, Miriam Di Re, Jie Gao, et al.. (2019). Genetic modification of primary human B cells to model high-grade lymphoma. Nature Communications. 10(1). 4543–4543. 36 indexed citations

Cooke, Susanna L., Darren Ennis, Lisa Evers, et al.. (2017). The Driver Mutational Landscape of Ovarian Squamous Cell Carcinomas Arising in Mature Cystic Teratoma. Clinical Cancer Research. 23(24). 7633–7640. 29 indexed citations

Eaves, Connie J., David J. H. F. Knapp, Colin A. Hammond, et al.. (2017). Molecular and biological analysis of human hematopoietic stem cells at single-cell resolution. Experimental Hematology. 53. S24–S24. 1 indexed citations

Nguyen, Long, Davide Pellacani, Sylvain Lefort, et al.. (2015). Barcoding reveals complex clonal dynamics of de novo transformed human mammary cells. Nature. 528(7581). 267–271. 86 indexed citations

10.

Girardot, Michael, C. Pecquet, Ilyas Chachoua, et al.. (2014). Persistent STAT5 activation in myeloid neoplasms recruits p53 into gene regulation. Oncogene. 34(10). 1323–1332. 31 indexed citations

11.

Cheung, Alice M.S., Long Nguyen, Annaïck Carles, et al.. (2013). Analysis of the clonal growth and differentiation dynamics of primitive barcoded human cord blood cells in NSG mice. Blood. 122(18). 3129–3137. 77 indexed citations

12.

Godfrey, Anna L., Nicholas Higgins, Philip Beer, Jenny I. O. Craig, & George S. Vassiliou. (2011). In situ thrombolysis for cerebral venous thrombosis complicating anti-leukemic therapy. Leukemia Research. 35(8). 1127–1129. 4 indexed citations

13.

Formenti, Federico, Philip Beer, Quentin P. P. Croft, et al.. (2011). Cardiopulmonary function in two human disorders of the hypoxia‐inducible factor (HIF) pathway: von Hippel‐Lindau disease and HIF‐2α gain‐of‐function mutation. The FASEB Journal. 25(6). 2001–2011. 80 indexed citations

14.

Beer, Philip, Christina A. Ortmann, Frank Stegelmann, et al.. (2010). Molecular mechanisms associated with leukemic transformation of MPL-mutant myeloproliferative neoplasms. Haematologica. 95(12). 2153–2156. 17 indexed citations

15.

Beer, Philip, Peter J. Campbell, & Anthony R. Green. (2010). Comparison of different criteria for the diagnosis of primary myelofibrosis reveals limited clinical utility for measurement of serum lactate dehydrogenase. Haematologica. 95(11). 1960–1963. 14 indexed citations

16.

Dawson, Mark A., Jayne Curry, Philip Beer, et al.. (2010). AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disorders. British Journal of Haematology. 150(1). 46–57. 41 indexed citations

17.

Beer, Philip & Anthony R. Green. (2009). Pathogenesis and management of essential thrombocythemia. Hematology. 2009(1). 621–628. 23 indexed citations

18.

Percy, Melanie J., Paul W. Furlow, Philip Beer, et al.. (2009). Erythropoietin synthesis is primarily regulated by the PHD2-HIF-2alpha-VHL axis as documented by HIF-2alpha associated familial erythrocytosis. British Journal of Haematology. 145. 44–45.

19.

Percy, Melanie J., Philip Beer, Gavin Campbell, et al.. (2008). Novel exon 12 mutations in the HIF2A gene associated with erythrocytosis. Blood. 111(11). 5400–5402. 97 indexed citations

20.

Furlow, Paul W., et al.. (2007). A novel Arg371His mutation in the HIF prolyl hydroxylase PHD2 is associated with erythrocytosis. Haematologica. 92. 87–87. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact